Little House Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,241
Closed -$207K 137
2021
Q2
$207K Buy
+2,241
New +$191K 0.11% 135

Other funds holding ARKG

Little House Capital's ARKG Position: Q3 2021 in Review

Little House Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 2,241 shares — an estimated $207K sold.

Little House Capital first reported a position in ARKG in Q2 2021 and held it in 1 quarter. The position peaked at $207K in Q2 2021. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Little House Capital reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Little House Capital sold 2,241 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $207K.
  • Little House Capital first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 1 quarter.
  • Little House Capital's ARK Genomic Revolution ETF position peaked at $207K in Q2 2021.
  • 468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Little House Capital's 13F filing for Q3 2021, filed 15 Nov 2021.